λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration
Authors
Keywords
-
Journal
Marine Drugs
Volume 17, Issue 3, Pages 140
Publisher
MDPI AG
Online
2019-02-28
DOI
10.3390/md17030140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the microenvironment in solid tumors
- (2018) Carmen Belli et al. CANCER TREATMENT REVIEWS
- Carrageenan: a review
- (2018) J. Necas et al. VETERINARNI MEDICINA
- Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer Cells
- (2018) Jan Ponert et al. MOLECULES
- A review on synthesis, properties and applications of natural polymer based carrageenan blends and composites
- (2017) Khalid Mahmood Zia et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent
- (2017) Nicolas Poupard et al. Marine Drugs
- Bioengineered heparins and heparan sulfates
- (2016) Li Fu et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent advances in the discovery of heparanase inhibitors as anti-cancer agents
- (2016) Li Jia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases
- (2016) Silvia Rivara et al. Future Medicinal Chemistry
- Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase
- (2016) Daniele Pala et al. GLYCOBIOLOGY
- MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin−/dermatan sulfate and hyaluronan biosynthesis
- (2016) Manuela Viola et al. GLYCOCONJUGATE JOURNAL
- Investigating Glycol-Split-Heparin-Derived Inhibitors of Heparanase: A Study of Synthetic Trisaccharides
- (2016) Minghong Ni et al. MOLECULES
- The US regulatory and pharmacopeia response to the global heparin contamination crisis
- (2016) Anita Y Szajek et al. NATURE BIOTECHNOLOGY
- Heparanase and cancer progression: New directions, new promises
- (2016) Gil Arvatz et al. Human Vaccines & Immunotherapeutics
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- Modulation of the binding of basic fibroblast growth factor and heparanase activity by purified λ-carrageenan oligosaccharides
- (2015) Ting-Ting Niu et al. CARBOHYDRATE POLYMERS
- Structural characterization and antioxidant activities of κ-carrageenan oligosaccharides degraded by different methods
- (2015) Yujiao Sun et al. FOOD CHEMISTRY
- Marine Polysaccharides from Algae with Potential Biomedical Applications
- (2015) Maria de Jesus Raposo et al. Marine Drugs
- Structural characterization of human heparanase reveals insights into substrate recognition
- (2015) Liang Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural characterization of human heparanase reveals insights into substrate recognition
- (2015) Liang Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy
- (2015) Min Luo et al. Scientific Reports
- Heparanase as a Target in Cancer Therapy
- (2014) Valentina Masola et al. CURRENT CANCER DRUG TARGETS
- Synthesis and Biological Evaluation of a Unique Heparin Mimetic Hexasaccharide for Structure–Activity Relationship Studies
- (2014) Sucharita Roy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Heparanase multiple effects in cancer
- (2014) Yona Nadir et al. THROMBOSIS RESEARCH
- Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments
- (2013) Anna Alekseeva et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Effects of sulfate group in red seaweed polysaccharides on anticoagulant activity and cytotoxicity
- (2013) Wanai Liang et al. CARBOHYDRATE POLYMERS
- Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase
- (2013) YANG LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Influence of red algal sulfated polysaccharides on blood coagulation and platelets activationin vitro
- (2013) Ekaterina V. Sokolova et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Selective sulfation of carrageenans and the influence of sulfate regiochemistry on anticoagulant properties
- (2012) Cristiano A. de Araújo et al. CARBOHYDRATE POLYMERS
- Anticoagulant Activity of a Unique Sulfated Pyranosic (1→3)-β-l-Arabinan through Direct Interaction with Thrombin
- (2012) Paula V. Fernández et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis
- (2011) He Zhou et al. PLoS One
- Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro
- (2011) CAMILLE ETTELAIE et al. Experimental and Therapeutic Medicine
- Overview of Anticoagulant Activity of Sulfated Polysaccharides from Seaweeds in Relation to their Structures, Focusing on those of Green Seaweeds
- (2010) M. Ciancia et al. CURRENT MEDICINAL CHEMISTRY
- Carrageenans: Biological properties, chemical modifications and structural analysis – A review
- (2009) Vanessa Leiria Campo et al. CARBOHYDRATE POLYMERS
- The Tainted Heparin Story: An Update
- (2009) Marco Guerrini et al. THROMBOSIS AND HAEMOSTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started